1-benzylpiperazine has been researched along with Intraocular Pressure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartolucci, G; Bonardi, A; Bua, S; Chiapponi, D; Chiaramonte, N; Dei, S; Durante, M; Ferraroni, M; Gratteri, P; Lucarini, L; Manetti, D; Masini, E; Nocentini, A; Romanelli, MN; Supuran, CT; Teodori, E | 1 |
1 other study(ies) available for 1-benzylpiperazine and Intraocular Pressure
Article | Year |
---|---|
2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents.
Topics: Animals; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Carbonic Anhydrase IX; Carbonic Anhydrases; Crystallography, X-Ray; Glaucoma; Humans; Intraocular Pressure; Male; Molecular Docking Simulation; Piperazines; Rabbits; Stereoisomerism | 2018 |